International Journal of Endocrinology

Inositol(s) from Bench to Bedside in Endocrinology and Gynecology

Publishing date
11 Nov 2016
Submission deadline
08 Jul 2016

Lead Editor

1Private Swiss University Institute, Chiasso, Switzerland

2Virginia Commonwealth University, Richmond, USA

3Alexandrovska University Hospital, Sofia, Bulgaria

4Infertility Treatment Center, Thessaloniki, Greece

5University of Modena and Reggio Emilia, Modena, Italy

Inositol(s) from Bench to Bedside in Endocrinology and Gynecology


The family of inositol(s) is a primordial group of ubiquitary molecules, which appeared at the beginning of evolution of life. Nature has used inositol(s) for several biological functions exploiting minimal changes in the structure. This family plays a pivotal role in regulating many metabolic pathways and hormonal signalling, and its essential function is well known in reproduction process.

Plenty of experimental and clinical data have shown that inositols play a pivotal role, as drugs, in treating several pathologies such as PCOS, metabolic syndrome, and gestational diabetes; these natural molecules allow avoiding congenital anomalies and they are very effective in improving assisted reproduction technology (ART); moreover, they have demonstrated promising anticancer activities as shown in numerous studies.

This special issue will take in consideration reviews, original research articles, short communications, and any scientific contribution providing both new insights from old data and updated results from experimental or clinical studies, thus pushing forward the boundaries of knowledge of inositol(s) in endocrinology and gynecology.

In addition, the contributions should open new outlooks, stimulating future researches and studies.

Potential topics include, but are not limited to:

  • Inositol(s) in endocrinology, namely, thyroid function and related pathologies, metabolic syndrome, and ART
  • Inositol(s) in gynaecology, that is, reproduction, PCOS treatment, and gestational anomalies
  • Inositol(s) and cancer
International Journal of Endocrinology
 Journal metrics
Acceptance rate35%
Submission to final decision48 days
Acceptance to publication46 days
Journal Citation Indicator0.510
Impact Factor3.257

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.